United States Gaucher Disease Drug Market Report 2017

May 2017 | 102 pages | ID: UBE2779EE1AEN
QYResearch

Abstracts

In this report, the United States Gaucher Disease Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Gaucher Disease Drug in these regions, from 2012 to 2022 (forecast).

United States Gaucher Disease Drug market competition by top manufacturers/players, with Gaucher Disease Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Sanofi
• Shire
• Actelion Pharma
• Pfizer

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Enzyme Replacement Therapy
• Substrate Reduction Therapy

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Gaucher Disease Drug for each application, including

• Non-Neuronopathic Gaucher Disease
• Neuronopathic Gaucher Disease

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Gaucher Disease Drug Market Report 2017

1 GAUCHER DISEASE DRUG OVERVIEW

1.1 Product Overview and Scope of Gaucher Disease Drug
1.2 Classification of Gaucher Disease Drug by Product Category
  1.2.1 United States Gaucher Disease Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Gaucher Disease Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Enzyme Replacement Therapy
  1.2.4 Substrate Reduction Therapy
1.3 United States Gaucher Disease Drug Market by Application/End Users
  1.3.1 United States Gaucher Disease Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Non-Neuronopathic Gaucher Disease
  1.3.3 Neuronopathic Gaucher Disease
1.4 United States Gaucher Disease Drug Market by Region
  1.4.1 United States Gaucher Disease Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Gaucher Disease Drug Status and Prospect (2012-2022)
  1.4.3 Southwest Gaucher Disease Drug Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Gaucher Disease Drug Status and Prospect (2012-2022)
  1.4.5 New England Gaucher Disease Drug Status and Prospect (2012-2022)
  1.4.6 The South Gaucher Disease Drug Status and Prospect (2012-2022)
  1.4.7 The Midwest Gaucher Disease Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Gaucher Disease Drug (2012-2022)
  1.5.1 United States Gaucher Disease Drug Sales and Growth Rate (2012-2022)
  1.5.2 United States Gaucher Disease Drug Revenue and Growth Rate (2012-2022)

2 UNITED STATES GAUCHER DISEASE DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Gaucher Disease Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Gaucher Disease Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Gaucher Disease Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Gaucher Disease Drug Market Competitive Situation and Trends
  2.4.1 United States Gaucher Disease Drug Market Concentration Rate
  2.4.2 United States Gaucher Disease Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Gaucher Disease Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES GAUCHER DISEASE DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Gaucher Disease Drug Sales and Market Share by Region (2012-2017)
3.2 United States Gaucher Disease Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Gaucher Disease Drug Price by Region (2012-2017)

4 UNITED STATES GAUCHER DISEASE DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Gaucher Disease Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Gaucher Disease Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Gaucher Disease Drug Price by Type (2012-2017)
4.4 United States Gaucher Disease Drug Sales Growth Rate by Type (2012-2017)

5 UNITED STATES GAUCHER DISEASE DRUG SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Gaucher Disease Drug Sales and Market Share by Application (2012-2017)
5.2 United States Gaucher Disease Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES GAUCHER DISEASE DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Sanofi
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Gaucher Disease Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Sanofi Gaucher Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Shire
  6.2.2 Gaucher Disease Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Shire Gaucher Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Actelion Pharma
  6.3.2 Gaucher Disease Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Actelion Pharma Gaucher Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.2 Gaucher Disease Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer Gaucher Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview

7 GAUCHER DISEASE DRUG MANUFACTURING COST ANALYSIS

7.1 Gaucher Disease Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Gaucher Disease Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Gaucher Disease Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Gaucher Disease Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES GAUCHER DISEASE DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Gaucher Disease Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Gaucher Disease Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Gaucher Disease Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Gaucher Disease Drug Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Gaucher Disease Drug
Figure United States Gaucher Disease Drug Market Size (K Doses) by Type (2012-2022)
Figure United States Gaucher Disease Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Enzyme Replacement Therapy Product Picture
Figure Substrate Reduction Therapy Product Picture
Figure United States Gaucher Disease Drug Market Size (K Doses) by Application (2012-2022)
Figure United States Sales Market Share of Gaucher Disease Drug by Application in 2016
Figure Non-Neuronopathic Gaucher Disease Examples
Figure Neuronopathic Gaucher Disease Examples
Figure United States Gaucher Disease Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Gaucher Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Gaucher Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Gaucher Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Gaucher Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Gaucher Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Gaucher Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Gaucher Disease Drug Sales (K Doses) and Growth Rate (2012-2022)
Figure United States Gaucher Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Gaucher Disease Drug Market Major Players Product Sales Volume (K Doses) (2012-2017)
Table United States Gaucher Disease Drug Sales (K Doses) of Key Players/Suppliers (2012-2017)
Table United States Gaucher Disease Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Gaucher Disease Drug Sales Share by Players/Suppliers
Figure 2017 United States Gaucher Disease Drug Sales Share by Players/Suppliers
Figure United States Gaucher Disease Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Gaucher Disease Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Gaucher Disease Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Gaucher Disease Drug Revenue Share by Players/Suppliers
Figure 2017 United States Gaucher Disease Drug Revenue Share by Players/Suppliers
Table United States Market Gaucher Disease Drug Average Price (USD/Dose) of Key Players/Suppliers (2012-2017)
Figure United States Market Gaucher Disease Drug Average Price (USD/Dose) of Key Players/Suppliers in 2016
Figure United States Gaucher Disease Drug Market Share of Top 3 Players/Suppliers
Figure United States Gaucher Disease Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Gaucher Disease Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Gaucher Disease Drug Product Category
Table United States Gaucher Disease Drug Sales (K Doses) by Region (2012-2017)
Table United States Gaucher Disease Drug Sales Share by Region (2012-2017)
Figure United States Gaucher Disease Drug Sales Share by Region (2012-2017)
Figure United States Gaucher Disease Drug Sales Market Share by Region in 2016
Table United States Gaucher Disease Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Gaucher Disease Drug Revenue Share by Region (2012-2017)
Figure United States Gaucher Disease Drug Revenue Market Share by Region (2012-2017)
Figure United States Gaucher Disease Drug Revenue Market Share by Region in 2016
Table United States Gaucher Disease Drug Price (USD/Dose) by Region (2012-2017)
Table United States Gaucher Disease Drug Sales (K Doses) by Type (2012-2017)
Table United States Gaucher Disease Drug Sales Share by Type (2012-2017)
Figure United States Gaucher Disease Drug Sales Share by Type (2012-2017)
Figure United States Gaucher Disease Drug Sales Market Share by Type in 2016
Table United States Gaucher Disease Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Gaucher Disease Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Gaucher Disease Drug by Type (2012-2017)
Figure Revenue Market Share of Gaucher Disease Drug by Type in 2016
Table United States Gaucher Disease Drug Price (USD/Dose) by Types (2012-2017)
Figure United States Gaucher Disease Drug Sales Growth Rate by Type (2012-2017)
Table United States Gaucher Disease Drug Sales (K Doses) by Application (2012-2017)
Table United States Gaucher Disease Drug Sales Market Share by Application (2012-2017)
Figure United States Gaucher Disease Drug Sales Market Share by Application (2012-2017)
Figure United States Gaucher Disease Drug Sales Market Share by Application in 2016
Table United States Gaucher Disease Drug Sales Growth Rate by Application (2012-2017)
Figure United States Gaucher Disease Drug Sales Growth Rate by Application (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Gaucher Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Sanofi Gaucher Disease Drug Sales Growth Rate (2012-2017)
Figure Sanofi Gaucher Disease Drug Sales Market Share in United States (2012-2017)
Figure Sanofi Gaucher Disease Drug Revenue Market Share in United States (2012-2017)
Table Shire Basic Information List
Table Shire Gaucher Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Shire Gaucher Disease Drug Sales Growth Rate (2012-2017)
Figure Shire Gaucher Disease Drug Sales Market Share in United States (2012-2017)
Figure Shire Gaucher Disease Drug Revenue Market Share in United States (2012-2017)
Table Actelion Pharma Basic Information List
Table Actelion Pharma Gaucher Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Actelion Pharma Gaucher Disease Drug Sales Growth Rate (2012-2017)
Figure Actelion Pharma Gaucher Disease Drug Sales Market Share in United States (2012-2017)
Figure Actelion Pharma Gaucher Disease Drug Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Gaucher Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Pfizer Gaucher Disease Drug Sales Growth Rate (2012-2017)
Figure Pfizer Gaucher Disease Drug Sales Market Share in United States (2012-2017)
Figure Pfizer Gaucher Disease Drug Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gaucher Disease Drug
Figure Manufacturing Process Analysis of Gaucher Disease Drug
Figure Gaucher Disease Drug Industrial Chain Analysis
Table Raw Materials Sources of Gaucher Disease Drug Major Players/Suppliers in 2016
Table Major Buyers of Gaucher Disease Drug
Table Distributors/Traders List
Figure United States Gaucher Disease Drug Sales Volume (K Doses) and Growth Rate Forecast (2017-2022)
Figure United States Gaucher Disease Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Gaucher Disease Drug Price (USD/Dose) Trend Forecast (2017-2022)
Table United States Gaucher Disease Drug Sales Volume (K Doses) Forecast by Type (2017-2022)
Figure United States Gaucher Disease Drug Sales Volume (K Doses) Forecast by Type (2017-2022)
Figure United States Gaucher Disease Drug Sales Volume (K Doses) Forecast by Type in 2022
Table United States Gaucher Disease Drug Sales Volume (K Doses) Forecast by Application (2017-2022)
Figure United States Gaucher Disease Drug Sales Volume (K Doses) Forecast by Application (2017-2022)
Figure United States Gaucher Disease Drug Sales Volume (K Doses) Forecast by Application in 2022
Table United States Gaucher Disease Drug Sales Volume (K Doses) Forecast by Region (2017-2022)
Table United States Gaucher Disease Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Gaucher Disease Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Gaucher Disease Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources